Joseph Hulihan M.D.
Net Worth
Last updated:
What is Joseph Hulihan M.D. net worth?
The estimated net worth of Dr. Joseph Hulihan M.D. is at least $1,070,163 as of 16 Feb 2024. He owns shares worth $36,633 as insider, has earned $55,790 from insider trading and has received compensation worth at least $977,740 in Marinus Pharmaceuticals, Inc..
What is the salary of Joseph Hulihan M.D.?
Dr. Joseph Hulihan M.D. salary is $488,870 per year as Chief Medical Officer in Marinus Pharmaceuticals, Inc..
How old is Joseph Hulihan M.D.?
Dr. Joseph Hulihan M.D. is 69 years old, born in 1956.
What stocks does Joseph Hulihan M.D. currently own?
As insider, Dr. Joseph Hulihan M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Marinus Pharmaceuticals, Inc. (MRNS) | Chief Medical Officer | 66,635 | $0.55 | $36,633 |
What does Marinus Pharmaceuticals, Inc. do?
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
Joseph Hulihan M.D. insider trading
Marinus Pharmaceuticals, Inc.
Dr. Joseph Hulihan M.D. has made 3 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,814 units of MRNS stock worth $28,084 on 16 Feb 2024.
The largest trade he's ever made was exercising 2,889 units of MRNS stock on 7 Aug 2023. As of 16 Feb 2024 he still owns at least 66,635 units of MRNS stock.
Marinus Pharmaceuticals key executives
Marinus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Joseph Hulihan M.D. (69) Chief Medical Officer
- Dr. Scott N. Braunstein M.D. (62) Chief Executive Officer, Pres & Director